1 EXHIBIT 10.42 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EXHIBIT 10.40 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENT This Amended...License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
RECITALSStock Subscription Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
ASSIGNMENT OF LICENSE AND RESTATED LICENSE AGREEMENTAssignment of License and Restated License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
1 EXHIBIT 10.41 AMENDED AND RESTATED SUBLICENSE AGREEMENT This Amended and Restated Sublicense Agreement ("Agreement") is effective this 20 day of November, 1996, between United States Biochemical Corporation, an Ohio corporation having its principal...Sublicense Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
